185 related articles for article (PubMed ID: 34422708)
1. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study.
Wan J; Wang X; Zhang Y; Xue X; Li Y; Liu Z; Han S; Chen M; Nie Y; Shi Y; Liang J; Wu K
Can J Gastroenterol Hepatol; 2021; 2021():1412663. PubMed ID: 34422708
[TBL] [Abstract][Full Text] [Related]
2. Trends in Pharmacologic Interventions for Preventing Recurrence of Crohn's Disease After Ileocolonic Surgery.
Ong MS; Grand RJ; Mandl KD
Inflamm Bowel Dis; 2016 Oct; 22(10):2432-41. PubMed ID: 27631599
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
Kim HJ; Oh SH; Lee SH; Kim YB; Kim DY; Park SH; Ye BD; Yang SK; Kim KM
Gut Liver; 2021 Nov; 15(6):851-857. PubMed ID: 33833134
[TBL] [Abstract][Full Text] [Related]
4. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
[TBL] [Abstract][Full Text] [Related]
5. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
[TBL] [Abstract][Full Text] [Related]
6. Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy.
Castillo-Regalado E; Ríos R; Aràjol C; Gely C; Márquez L; Calafat M; González-Muñoza C; Cañete F; Mesonero F; Guardiola J; Garcia-Planella E; Mañosa M; Domènech E
Gastroenterol Hepatol; 2023 Mar; 46(3):164-170. PubMed ID: 36179946
[TBL] [Abstract][Full Text] [Related]
7. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
Arora U; Kedia S; Garg P; Bopanna S; Jain S; Yadav DP; Goyal S; Gupta V; Sahni P; Pal S; Dash NR; Madhusudhan KS; Sharma R; Makharia G; Ahuja V
Dig Dis Sci; 2018 Jun; 63(6):1592-1599. PubMed ID: 29611078
[TBL] [Abstract][Full Text] [Related]
8. Isolated colonic Crohn's disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease.
Xu Y; Guo Z; Cao L; Xie T; Shen W; Li Y; Gong J; Zhu W
Clin Nutr; 2019 Aug; 38(4):1629-1635. PubMed ID: 30193873
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
10. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
11. Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.
Schreiber S; Howaldt S; Raedler A
Gut; 1994 Aug; 35(8):1081-5. PubMed ID: 7926910
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.
de Franchis R; Omodei P; Ranzi T; Brignola C; Rocca R; Prada A; Pera A; Vecchi M; Del Piano M; Ferrara A; Belloli C; Piodi L; Framarin L; Astegiano M; Riccioli FA; Meucci G
Aliment Pharmacol Ther; 1997 Oct; 11(5):845-52. PubMed ID: 9354191
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists.
Gearry RB; Ajlouni Y; Nandurkar S; Iser JH; Gibson PR
Inflamm Bowel Dis; 2007 Aug; 13(8):1009-15. PubMed ID: 17352386
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
[TBL] [Abstract][Full Text] [Related]
15. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
Morar PS; Hodgkinson JD; Thalayasingam S; Koysombat K; Purcell M; Hart AL; Warusavitarne J; Faiz O
J Crohns Colitis; 2015 Jun; 9(6):483-91. PubMed ID: 25796553
[TBL] [Abstract][Full Text] [Related]
16. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.
Louis E; Collard A; Oger AF; Degroote E; Aboul Nasr El Yafi FA; Belaiche J
Gut; 2001 Dec; 49(6):777-82. PubMed ID: 11709511
[TBL] [Abstract][Full Text] [Related]
17. Bowel Stiffness Assessed by Shear-Wave Ultrasound Elastography Predicts Disease Behavior Progression in Patients With Crohn's Disease.
Chen YJ; He JS; Xiong SS; Li MY; Chen SL; Chen BL; Qiu Y; Xia QQ; He Y; Zeng ZR; Chen MH; Xie XY; Mao R
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00684. PubMed ID: 38270207
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
19. 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.
Duricova D; Pedersen N; Elkjaer M; Jensen JK; Munkholm P
J Crohns Colitis; 2010 Nov; 4(5):575-81. PubMed ID: 21122562
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.
Thia KT; Sandborn WJ; Harmsen WS; Zinsmeister AR; Loftus EV
Gastroenterology; 2010 Oct; 139(4):1147-55. PubMed ID: 20637205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
